Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Amortization of Deferred Charges (2018 - 2026)

Omeros (OMER) posted Amortization of Deferred Charges of -$7.8 million for Q4 2025, down 633.88% sequentially from $1.5 million in Q3 2025, and down 6.05% YoY from -$8.3 million in Q4 2024.

Analysis

Omeros (OMER) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends

Omeros has reported Amortization of Deferred Charges for 8 years, with the latest figure at -$7.8 million in Q4 2025.

  • Quarterly Amortization of Deferred Charges fell 6.05% year-over-year to -$7.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$6.2 million (up 5.39% YoY) and the FY2025 annual result came in at -$5.6 million, down 19.16% from the prior year.
  • Amortization of Deferred Charges declined to -$7.8 million in Q4 2025 per OMER's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $2.1 million in Q3 2024 and troughed at -$7.8 million in Q4 2025.
  • A 5-year average of -$585631.6 and a median of $440000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
  • The sharpest annual moves came in 2022 and 2024: Amortization of Deferred Charges tumbled 409.32% in 2022, then jumped 319.55% in 2024.
  • Over 5 years, Amortization of Deferred Charges stood at $440000.0 in 2021, then sank by 409.32% to -$1.4 million in 2022, then fell by 6.54% to -$1.4 million in 2023, then plunged by 406.21% to -$7.3 million in 2024, then slipped by 6.05% to -$7.8 million in 2025.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered -$7.8 million, $1.5 million, and $92000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.44 Mn
Mar 31, 2026 1.46 Mn
Dec 31, 2025 -10.31 Mn
Sep 30, 2025 1.51 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 -1.91 Mn
Dec 31, 2024 -7.34 Mn
Sep 30, 2024 2.06 Mn
Jun 30, 2024 599,000.00
Mar 31, 2024 1.39 Mn
Dec 31, 2023 403,000.00
Sep 30, 2023 491,000.00
Jun 30, 2023 482,000.00
Mar 31, 2023 477,000.00
Dec 31, 2022 469,000.00
Sep 30, 2022 461,000.00
Jun 30, 2022 454,000.00
Mar 31, 2022 446,000.00
Dec 31, 2021 440,000.00
Sep 30, 2021 434,000.00